RAPID MICRO BIOSYSTEMS, INC. Quarterly Nonoperating Income (Expense) in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Rapid Micro Biosystems, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2020 to Q2 2024.
  • Rapid Micro Biosystems, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $815K, a 21.9% decline year-over-year.
  • Rapid Micro Biosystems, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $3.86M, a 13.2% increase year-over-year.
  • Rapid Micro Biosystems, Inc. annual Nonoperating Income (Expense) for 2023 was $4.13M, a 125% increase from 2022.
  • Rapid Micro Biosystems, Inc. annual Nonoperating Income (Expense) for 2022 was $1.84M.
  • Rapid Micro Biosystems, Inc. annual Nonoperating Income (Expense) for 2021 was -$26.2M, a 309% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $3.86M $815K -$229K -21.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $4.09M $954K -$38K -3.83% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $4.13M $1.02M +$204K +24.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-01
Q3 2023 $3.92M $1.07M +$513K +92.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $3.41M $1.04M +$673K +181% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 $2.74M $992K +$900K +978% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $1.84M $820K +$835K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 $1M $554K +$13.4M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$12.4M $371K +$1.32M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$13.7M $92K +$12.5M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$26.2M -$15K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 -$12.8M -$12M -1380% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$951K +$2.23M +70.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$12.4M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 -$868K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$3.18M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.